Better Infection Prevention with On-Demand Molecular Diagnostics

Better and faster answers from diagnostic tests enable clinicians to enhance treatment and infection prevention efforts.

Only Cepheid delivers these fast and accurate results so you can:

  • Get easy to interpret answers for more cost-effective patient management1

  • Improve implementation of infection prevention policies2

  • Support better clinical decisions to improve patient outcomes3

  • Reduce the number of surgical site infections by using targeted decolonization strategies4

  • Elevate antibiotic stewardship and reduce unnecessary therapy costs5

  • Minimize follow-up visits by optimizing treatment early6

Impact of Rapid Diagnostics

Shortened hospital length of stay by 2.5 days3

Decreased lethal bloodstream infections in patients by 36%3

Reduced time to effective therapy by 5 hours3

Webinars

Related Product Links

Xpert® Carba-R

Xpert® Carba-R

Detection and differentiation of KPC, NDM, VIM, IMP-1, and OXA-48 in 50 minutes
Xpert® MRSA NxG

Xpert® MRSA NxG

Active MRSA surveillance testing in around 70 minutes
Xpert® SA Nasal Complete

Xpert® SA Nasal Complete

Pre-surgical S. aureus and MRSA in about 65 minutes
Xpert® MRSA/SA SSTI

Xpert® MRSA/SA SSTI

Detect MRSA & SA skin and soft tissue infection in about one hour
Xpert® vanA/vanB

Xpert® vanA/vanB

Rapid VRE screening for active outbreak prevention and control in around 48 minutes
Xpert® C. difficile BT

Xpert® C. difficile BT

Detection of Clostridium difficile infection with an independent call-out of binary toxin and differentiation of the 027 strain in around 45 minutes
Xpert® MTB/RIF Ultra

Xpert® MTB/RIF Ultra

Enhanced performance in detecting drug-sensitive and -resistant Tuberculosis in less than 80 minutes
Xpert® CT/NG

Xpert® CT/NG

Fast and Accurate Diagnosis of Chlamydia and Gonorrhea
Xpert® TV

Xpert® TV

The First MolecularTrichomonas VaginalisTest for Both Women and Men

1.Casari E, et al. Reducing rates of Clostridium difficile infection by switching to a stand-alone NAAT with clear sampling criteria. Antimicrob Resist Infect Control. 2018;7:40.

2.Birgand G, et al. Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs. Antimicrob Resist Infect Control. 2013 Nov 4;2(1):30.

3.Wenzler E, Using rapid diagnostics to fight resistance. Infectious Disease Special Edition. May 30, 2018. https://www.idse.net/Resistance--Stewardship/Article/09-15/Using-Rapid-
Diagnostics-to-Fight-Resistance/48730. Accessed 12 July 2018

4.Bauer KA, et al. An Antimicrobial Stewardship Program’s Impact with Rapid olymerase chain reaction methicillin-resistant/ Staphylococcus Blood Culture Test in Patients with Staphylococcus Bacteremia. ClinInfect Dis. 2010; 51(9):1074–1080.

5.Humphreys H, et al. Staphylococcus and surgical site infections: benefits of screening and decolonization before surgery. J Hosp Infect. 2016. Nov;94(3):295-304.

6.Rudd K, et al. Molecular Diagnostics Can Lead To Early Optimization of Antimicrobial Therapy for Staphylococcal Bacteremia: Experience at a Large Tertiary-Care VA Medical Center. Open Forum Infectious Diseases, Volume 3, Issue suppl_1, 1 December 2016, 1863. Accessed 12 July 2018.